Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Is a private Joint-stock enterprise with strong background, specialized in manufacturing more than 100 types of products, including APIs, advanced pharmaceutical intermediates and medical formulations and so on. Now it has become one of the largest manufacturers in Ribose, Nucleic Acid and relative pharmaceutical intermediates in the world.

Cheng Yi Pharma, was established in the middle 60' s of last century, while through 40 years innovation and growth, it has successfully ranked into a main manufacturer for the pharmaceutical products. Cheng Yi Pharmaceutical Co., Ltd. not only built a strict cGMP quality assurance system, thoroughly certificated GMP by SFDA, ISO9001 and ISO14001 certificated, as well compliance with pharmaceutical regulatory requirements in developed countries of European and American, but also respectively registered DMF for several products in 29 countries and areas including American FDA, European Union, Australia, Canada and so on. Cheng Yi Pharma passed GMP audit by Australia TGA and successfully received inspection by many worldwide well-known multinational pharmaceutical corporations. Cheng Yi Pharma, on vigorously developing, was also established an enterprise in Jiangsu province, named Jiangsu Cheng Yi Pharmaceutical Co.,Ltd. which mainly manufactures API and intermediates by fermentation process.

Cheng Yi Pharma has ten GMP workshops and one pilot plant. It can not only scale manufactures pharmaceutical products and intermediates bulky in good quality, but also can supply from small samples with kilogram grade to small batch size with hundred kilograms according to customer's requirement for the new-drug research. Cheng Yi Pharma gained high reputation from customers inland and overseas with its abundant experience in research, mature and high-efficient manufacturing process, as well the integrated products series and the earnest sincere service from end to end. The products are exported to more than twenty countries and regions including America , Japan , South Africa and Europe , South-east Asian and so on.

Cheng Yi Pharma looks forward to cooperating with you, and be "win-win" together with you.

Chengyi Milestones

Oct. 1966: The company was founded under the name of Tong Shan Pharmaceutical Factory;

Dec. 1989: An advanced injections workshop was built, which was the best at the time in the south of Zhejiang ; Oct. 1991: The company name was changed to Wenzhou No. 3 Pharmaceutical Factory; Mar. 1992: The dedicated workshop 201 was built. The company became the leader in manufacturing Ribavirin in China ; Jul. 1995: The company became a leader in manufacturing Acyclovir at the time; Dec. 1998: Inspected and approved by TGA Australia . Apr. 2001: The company was privatized. The name was changed to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Nov. 2001: Inspected and approved by SDA China and obtained GMP certificate; Jan. 2002: ISO9001 certified. Mar. 2002: ISO14001 certified Apr. 2002: Reviewed by TGA Australia . Jun. 2003: ISO14001 certified by RAB America Apr. 2004: Jiangsu Cheng Yi Pharmaceutical Co., Ltd was founded. Nov. 2005: Inspected and approved by SFDA, covering Torasemide and Acetylcysteine APIs.

Dec. 2005: Approved by MHRA GMP on-site audit Mar. 2006: Reviewed and approved by TGA Australia at the third time May. 2008: Cheng Yi obtained COS/CEP certificate from EDQM in EU.

Culture & Values

Cheng Yi Pharma adheres to the policy "human-oriented enterprise", advocates and cultivates enterprise culture actively. It has invested a huge number of money to invite East China University of Science and Technology to establish adults' university in plants since 2001. Moreover, it has encouraged and subsized more than 60 staff to have further education at schools. In order to enhance physical and literary qualities, as well as cohesiveness and teamwork of personnel, our company held several activities, such as contest on company knowledge and culture, professional information training, and various kinds of sports and recreational activities.

Objectives of Enterprise Culture: Sincerity, Realism, innovation

Object:

To become a leading pharmaceutical company in China and a leading manufacturer of nucleic acids in the world through a focused business strategy.

General Manager